← Back to Screener
Bluejay Diagnostics, Inc. Common Stock (BJDX)
Price$4.80
Growth ScoreF
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-15.62%
Price vs S&P 500 (4W)179.08%
VGM Score35.17
Market Capitalization$4.97M
All Metrics
Book Value / Share (Quarterly)$4.04
P/TBV (Annual)0.33x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-6.43
Price vs S&P 500 (YTD)71.62%
EPS (TTM)$-53.96
10-Day Avg Trading Volume7.96M
EPS Excl Extra (TTM)$-53.96
EPS (Annual)$-61.01
ROI (Annual)-114.43%
Gross Margin (Annual)20.00%
Cash / Share (Quarterly)$3.56
ROA (Last FY)-96.20%
Revenue Growth TTM (YoY)-100.00%
EBITD / Share (TTM)$-15.74
ROE (5Y Avg)-138.17%
Cash Flow / Share (Annual)$-41.21
P/B Ratio1.19x
P/B Ratio (Quarterly)0.46x
Net Income / Employee (Annual)$-1,141,400
Net Interest Coverage (TTM)-10.40x
ROA (TTM)-115.00%
EPS Incl Extra (Annual)$-61.01
Current Ratio (Annual)4.88x
Quick Ratio (Quarterly)2.62x
3-Month Avg Trading Volume1.04M
52-Week Price Return-21.05%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.21
P/S Ratio (Annual)19.87x
Asset Turnover (Annual)0.02x
52-Week High$16.68
EPS Excl Extra (Annual)$-61.01
CapEx CAGR (5Y)98.32%
26-Week Price Return-7.69%
Quick Ratio (Annual)4.64x
13-Week Price Return152.63%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.81x
Enterprise Value$1.29M
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-3720.00%
Cash / Share (Annual)$34.18
3-Month Return Std Dev209.59%
Net Income / Employee (TTM)$-1,150,500
ROE (Last FY)-114.61%
Net Interest Coverage (Annual)-3.84x
EPS Basic Excl Extra (Annual)$-61.01
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-53.96
ROI (TTM)-143.98%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$11.42
Price vs S&P 500 (52W)-45.42%
Year-to-Date Return79.78%
5-Day Price Return121.20%
EPS Normalized (Annual)$-61.01
ROA (5Y Avg)-100.39%
Net Profit Margin (Annual)-3720.00%
Month-to-Date Return124.30%
Cash Flow / Share (TTM)$-9.03
EBITD / Share (Annual)$-61.28
Operating Margin (Annual)-3824.00%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-137.64%
LT Debt / Equity (Quarterly)0.25x
EPS Basic Excl Extra (TTM)$-53.96
P/TBV (Quarterly)0.73x
P/B Ratio (Annual)0.20x
Book Value / Share (Annual)$39.54
Price vs S&P 500 (13W)144.38%
Beta0.45x
Revenue / Share (TTM)$0.00
ROE (TTM)-144.27%
52-Week Low$1.62
gGradeF
mGradeB
vgmGradeD
Show chart for
Analyst Recommendations
Apr 2024
May 2024
Jun 2024
Jul 2024
2.17
2.17
2.17
2.17
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BJDXBluejay Diagnostics, Inc. Common Stock | — | F | B | $4.80 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Bluejay Diagnostics develops the Symphony System, a rapid, cost-effective near-patient testing platform for sepsis diagnosis and monitoring. Its first product, an IL-6 sepsis test, delivers results in approximately 20 minutes, enabling faster clinical decision-making and improved patient outcomes. The platform addresses a critical clinical need in acute care settings where rapid sepsis diagnosis is essential for treatment efficacy.